tiprankstipranks
Advertisement

RFG - ETF AI Analysis

Compare

Top Page

RFG

Invesco S&P Midcap 400 Pure Growth ETF (RFG)

Rating:72Outperform
Price Target:
RFG, the Invesco S&P Midcap 400 Pure Growth ETF, has an overall rating that reflects generally strong underlying companies with some valuation and financial risks to watch. Top holdings like TechnipFMC, Woodward, ATI, and Medpace support the fund’s quality through solid financial performance, positive earnings commentary, and favorable technical trends, while names such as Arrowhead Pharmaceuticals and DigitalOcean introduce more risk due to financial challenges, high leverage, or stretched valuations. The main risk factor is that many key holdings show signs of high valuations or overbought conditions, which could make the fund more sensitive to market pullbacks.
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and in recent months, indicating solid momentum.
High-Growth Top Holdings
Most of the largest positions have delivered strong year-to-date gains, helping drive the fund’s overall returns.
Sector Diversification Within Growth
Holdings spread across industrials, technology, health care, and several other sectors help reduce the impact if any one industry weakens.
Negative Factors
Mid-Cap Growth Volatility
Because it focuses on mid-size growth companies, the fund may experience larger price swings than more conservative, broad-market ETFs.
Heavy U.S. Exposure
With almost all assets in U.S. stocks, the ETF offers little geographic diversification if the U.S. market struggles.
Moderate Expense Ratio
The fund’s fee is not especially low, which slightly reduces the net return investors keep over time.

RFG vs. SPDR S&P 500 ETF (SPY)

RFG Summary

RFG is the Invesco S&P Midcap 400 Pure Growth ETF, which follows the S&P Mid Cap 400 Pure Growth index. It focuses on medium‑sized U.S. companies that are growing quickly, based on things like rising sales and earnings. The fund holds a mix of sectors, with a lot in industrials, technology, and health care. Examples of companies inside the ETF include TechnipFMC and Arrowhead Pharmaceuticals. Someone might invest in RFG to seek higher long‑term growth than large, slower‑moving companies, while still being diversified across many stocks. A key risk is that mid‑cap growth stocks can be quite volatile and can go up and down sharply with the market.
How much will it cost me?The Invesco S&P Midcap 400 Pure Growth ETF (RFG) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This cost is slightly higher than average because the fund is actively managed to focus on mid-cap growth stocks, requiring more research and strategy compared to passively managed ETFs. It’s designed for investors seeking targeted exposure to companies with strong growth potential.
What would affect this ETF?The Invesco S&P Midcap 400 Pure Growth ETF (RFG) could benefit from economic growth and innovation within sectors like Industrials, Health Care, and Technology, which make up a significant portion of its holdings. However, it may face challenges if interest rates rise, as growth stocks often become less attractive in such environments, or if economic uncertainty impacts mid-cap companies more heavily than larger firms. Regulatory changes or sector-specific disruptions could also influence the performance of its top holdings.

RFG Top 10 Holdings

RFG is leaning hard into U.S. industrial and tech names, with mid-cap growth stars doing most of the heavy lifting. Sterling Infrastructure and Carpenter Technology are powering ahead, giving the fund a strong industrial backbone, while TTM Technologies and Vicor add spark from the tech side with rising momentum tied to electronics and power solutions. DigitalOcean is another bright spot, riding the AI and cloud wave, though its stretched finances could wobble the ride. On the flip side, TechnipFMC and Rambus have been more mixed lately, occasionally tugging at performance rather than pushing it forward.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Sterling Infrastructure2.56%$8.68M$19.59B162.56%
71
Outperform
Carpenter Technology2.44%$8.25M$27.71B97.56%
75
Outperform
TechnipFMC2.22%$7.53M$28.73B123.83%
80
Outperform
Arrowhead Pharmaceuticals2.16%$7.31M$10.47B387.08%
57
Neutral
Woodward2.02%$6.83M$23.41B53.75%
79
Outperform
Halozyme1.98%$6.69M$9.23B37.86%
73
Outperform
DigitalOcean Holdings1.95%$6.62M$12.41B308.68%
73
Outperform
MasTec1.87%$6.33M$26.04B91.99%
74
Outperform
ATI1.74%$5.88M$25.41B100.62%
78
Outperform
Medpace Holdings1.67%$5.65M$15.36B70.92%
79
Outperform

RFG Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
62.35
Negative
100DMA
59.91
Negative
200DMA
56.63
Positive
Market Momentum
MACD
-0.72
Positive
RSI
36.17
Neutral
STOCH
4.83
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RFG, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 62.15, equal to the 50-day MA of 62.35, and equal to the 200-day MA of 56.63, indicating a neutral trend. The MACD of -0.72 indicates Positive momentum. The RSI at 36.17 is Neutral, neither overbought nor oversold. The STOCH value of 4.83 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RFG.

RFG Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$338.44M0.35%
72
Outperform
$584.97M0.73%
67
Neutral
$353.20M0.31%
69
Neutral
$166.67M0.80%
74
Outperform
$143.09M0.60%
59
Neutral
$112.97M0.85%
68
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RFG
Invesco S&P Midcap 400 Pure Growth ETF
60.95
10.27
20.26%
FNY
First Trust Mid Cap Growth AlphaDEX Fund
NUMG
Nuveen ESG Mid-Cap Growth ETF
GLRY
Inspire Faithward Mid Cap Momentum ESG ETF
FRTY
Alger Mid Cap 40 ETF
TMFM
Motley Fool Mid-Cap Growth ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement